INAF.JK Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 Jun 2024 @ 00:55):

Stats
Today's Volume	15 100.00
Average Volume	190 815
Market Cap	626.05B
EPS	IDR0 ( 2024-05-27 )
Next earnings date	( IDR0 ) 2024-07-31
Last Dividend	IDR0 ( N/A )
Next Dividend	IDR0 ( N/A )
P/E	-1.430
ATR14	IDR0 (0.00%)

PT Indofarma Tbk Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

PT Indofarma Tbk Financials

Annual	2022
Revenue:	IDR1 144.11B
Gross Profit:	IDR-110.11B (-9.62 %)
EPS:	IDR-138.25

FY	2022
Revenue:	IDR1 144.11B
Gross Profit:	IDR-110.11B (-9.62 %)
EPS:	IDR-138.25

FY	2021
Revenue:	IDR2 901.99B
Gross Profit:	IDR451.65B (15.56 %)
EPS:	IDR-13.63

FY	2020
Revenue:	IDR1 715.59B
Gross Profit:	IDR400.60B (23.35 %)
EPS:	IDR0.0100

Financial Reports:

No articles found.

PT Indofarma Tbk Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

PT Indofarma Tbk

PT Indofarma Tbk, together with its subsidiaries, manufactures and markets pharmaceutical products in Indonesia. The company trades in and distributes drugs, medical devices, medical supplies, extracts, and herbals; and operates laboratory. It also provides COVID-19 test services, including rapid diagnostic test antigen; reverse transcription polymerase chain reaction, and genose. The company also exports its products. The company was formerly known as PT Indofarma (Persero) Tbk. PT Indofarma Tbk was founded in 1918 and is headquartered in Bekasi, Indonesia. PT Indofarma Tbk operates as a subsidiary of PT. Bio Farma.